Genzyme Details Market Potential of Alemtuzumab for MS
- Details
- Category: Genzyme
![Genzyme Genzyme](/images/stories/logo/genzyme.gif)
EpiTherapeutics and Abbott Enter Into Oncology Collaboration on Epigenetic Targets
- Details
- Category: Abbott
![Abbott Abbott](/images/stories/logo/abbott.gif)
Merck KGaA and sanofi-aventis to Investigate Novel Combinations Against Cancer
- Details
- Category: Merck Group
![Merck KGaA Merck KGaA](/images/stories/logo/merck_kgaa.gif)
Roche provides update on Avastin following reviews in Europe and the United States
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
- In the European Union, Avastin confirmed as a valuable treatment option in combination with paclitaxel
- In the United States, the company will request a hearing to maintain Avastin as a treatment option for metastatic breast cancer
Lundbeck enters into drug discovery collaboration with Zenobia and Vernalis
- Details
- Category: Lundbeck
![Lundbeck Lundbeck](/images/stories/logo/lundbeck.gif)
Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc.
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
Lundbeck to establish a strong, dedicated sales force behind Lexapro® in China
- Details
- Category: Lundbeck
![Lundbeck Lundbeck](/images/stories/logo/lundbeck.gif)
More Pharma News ...
- XGEVA(TM) (Denosumab) Significantly Improved Bone Metastasis-Free Survival
- Genzyme Reiterates Board's Position on sanofi-aventis Tender Offer
- Bayer: 35 million Euros for the expansion of the development of biologicals
- Young Children In Developing World Receive Accelerated Access to Pfizer's Prevenar 13 Vaccine
- Middle East and North African leaders seek solutions to diabetes threat
- LUX-Lung 1 trial suggests benefit from afatinib* in lung cancer patients
- GSK to acquire Nanjing MeiRui Pharmaceuticals in China